Infumorph (Preservative-free Morphine Sulfate Sterile Solution), 20 mL ampul, Rx only, Manufactur...

FDA Drug Recall #D-0392-2024 — Class II — March 12, 2024

Recall Summary

Recall Number D-0392-2024
Classification Class II — Moderate risk
Date Initiated March 12, 2024
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Hikma Pharmaceuticals USA Inc.
Location Cherry Hill, NJ
Product Type Drugs
Quantity 22,644 ampuls

Product Description

Infumorph (Preservative-free Morphine Sulfate Sterile Solution), 20 mL ampul, Rx only, Manufactured by Hikma Berkeley Heights, NJ 07922, NDC 0641-6039-01

Reason for Recall

The filter included in the carton has an expiration date that has expired prior to the expiration date of the actual product lot.

Distribution Pattern

Nationwide within the United States

Lot / Code Information

Lot #: 052001, 052003, Exp. Date 11/2024; 023012, 023014, Exp. Date 08/2024

Other Recalls from Hikma Pharmaceuticals USA Inc.

Recall # Classification Product Date
D-0551-2025 Class II Lorazepam Injection, USP, 2 mg/mL, 25 x 1mL via... Jul 22, 2025
D-0635-2024 Class I Acetaminophen Injection, 1,000 mg per 100 mL (1... Jul 8, 2024
D-0574-2023 Class II Lorazepam Injection, USP, 2mg/mL, 1 mL vial (ND... May 11, 2023
D-0090-2023 Class II Ganciclovir for Injection, USP, 500mg per vial,... Dec 16, 2022
D-1310-2022 Class II Lorazepam Injection, USP, 4mg/mL, 1 mL vial, 2... Jul 11, 2022

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.